Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.950
-0.010 (-0.51%)
At close: Apr 28, 2026, 4:00 PM EDT
1.940
-0.010 (-0.51%)
After-hours: Apr 28, 2026, 7:55 PM EDT
Palisade Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | - | - | 0.25 | - | - | |
| Gross Profit | - | - | 0.25 | - | - | |
| Selling, General & Admin | 7.86 | 5.8 | 6.2 | 8.76 | 9.31 | |
| Research & Development | 10.19 | 9.06 | 6.89 | 6.55 | 2.43 | |
| Operating Expenses | 18.06 | 14.86 | 13.1 | 15.31 | 11.74 | |
| Operating Income | -18.06 | -14.86 | -12.85 | -15.31 | -11.74 | |
| Interest Expense | -0.01 | -0.01 | -0.02 | -0.01 | -3.08 | |
| Interest & Investment Income | - | - | 0.7 | 0.2 | - | |
| Other Non Operating Income (Expenses) | 1.29 | 0.43 | 0.09 | 1.27 | 18.04 | |
| EBT Excluding Unusual Items | -16.78 | -14.44 | -12.08 | -13.85 | 3.22 | |
| Merger & Restructuring Charges | - | - | -0.23 | -0.41 | - | |
| Other Unusual Items | - | - | - | - | 0.28 | |
| Pretax Income | -16.78 | -14.44 | -12.3 | -14.26 | -26.62 | |
| Net Income | -16.78 | -14.44 | -12.3 | -14.26 | -26.62 | |
| Preferred Dividends & Other Adjustments | - | - | 0.02 | 0.29 | - | |
| Net Income to Common | -16.78 | -14.44 | -12.32 | -14.55 | -26.62 | |
| Shares Outstanding (Basic) | 56 | 1 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 56 | 1 | 0 | 0 | 0 | |
| Shares Change (YoY) | 3830.18% | 210.62% | 677.03% | 370.85% | - | |
| EPS (Basic) | -0.30 | -10.19 | -27.01 | -247.89 | -2144.20 | |
| EPS (Diluted) | -0.30 | -10.19 | -27.01 | -247.95 | -2546.13 | |
| Free Cash Flow | -10.85 | -12.19 | -11.14 | -13.37 | -14.77 | |
| Free Cash Flow Per Share | -0.20 | -8.61 | -24.42 | -227.82 | -1185.25 | |
| Gross Margin | - | - | 100.00% | - | - | |
| Operating Margin | - | - | -5138.00% | - | - | |
| Profit Margin | - | - | -4926.40% | - | - | |
| Free Cash Flow Margin | - | - | -4454.80% | - | - | |
| EBITDA | -18.05 | -14.86 | -12.84 | -15.31 | -11.74 | |
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0 | |
| EBIT | -18.06 | -14.86 | -12.85 | -15.31 | -11.74 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.